Crossmark

Biosimilars in Malaysia: Regulatory Framework, Approved Products, and Adverse Effects

Published Online: 2020-11-24

Published Print: 2021-05

Authors

Mohd Sani, Noraisyah

Aziz, Zoriah https://orcid.org/0000-0001-7113-9323
Kamarulzaman, Adeeba
License Information

Text and Data Mining valid from 2020-11-24

Version of Record valid from 2020-11-24
More Information

Article History

Received: 6 September 2020

Accepted: 10 November 2020

First Online: 24 November 2020

Compliance with Ethical Standards

:

: The authors declare that there is no conflict of interest.

Document is current